Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Holding DE:137?
Track your performance easily

Aldeyra Therapeutics (137) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Aldeyra Therapeutics’s (137) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Aldeyra Therapeutics is a Buy.
Aldeyra Therapeutics’s (137) 20-Day exponential moving average is 4.90, while Aldeyra Therapeutics’s (137) share price is €4.731, making it a Sell.
Aldeyra Therapeutics’s (137) 50-Day exponential moving average is 4.70, while Aldeyra Therapeutics’s (137) share price is €4.731, making it a Buy.

Aldeyra Therapeutics (137) Pivot Points

Oct 10, 2024, 09:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.76
4.76
4.76
4.76
4.76
4.76
4.76
Fibonacci
4.76
4.76
4.76
4.76
4.76
4.76
4.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aldeyra Therapeutics (137) Moving Averages

Oct 10, 2024, 09:09 PM
Period
Simple
Exponential
MA5
4.76Sell
4.77Sell
MA10
4.77Sell
4.82Sell
MA20
5.01Sell
4.90Sell
MA50
4.74Sell
4.70Buy
MA100
4.07Buy
4.30Buy
MA200
3.68Buy
3.77Buy
Aldeyra Therapeutics’s (137) 10-Day exponential moving average is 4.82, while Aldeyra Therapeutics’s (137) share price is €4.731, making it a Sell.
Aldeyra Therapeutics’s (137) 100-Day exponential moving average is 4.30, while Aldeyra Therapeutics’s (137) share price is €4.731, making it a Buy.
Aldeyra Therapeutics’s (137) stock price is €4.731 and Aldeyra Therapeutics’s (137) 50-day simple moving average is 4.74, creating a Sell signal.
Aldeyra Therapeutics’s (137) stock price is €4.731 and Aldeyra Therapeutics’s (137) 100-day simple moving average is 4.07, creating a Buy signal.
Aldeyra Therapeutics’s (137) stock price is €4.731 and Aldeyra Therapeutics’s (137) 200-day simple moving average is 3.68, creating a Buy signal.

Aldeyra Therapeutics (137) Technical Indicators

Oct 10, 2024, 09:09 PM
Name
Value
Implied Action
RSI (14)
44.76
Neutral
STOCH (9,6)
51.12
Neutral
STOCHRSI (14)
20.20
Neutral
MACD (12,26)
-0.05
Buy
ADX (14)
17.39
Buy
Williams %R
-87.99
Buy
CCI (14)
-75.58
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
43.17
Neutral
ROC
-9.92
Sell
Aldeyra Therapeutics’s (137) Relative Strength Index (RSI) is 44.76, creating a Neutral signal.
Aldeyra Therapeutics’s (137) Trend Strength Indicator (ADX) is 17.39, creating a Buy signal.
Aldeyra Therapeutics’s (137) Commodity Channel Index (CCI) is -75.58, creating a Neutral signal.
Aldeyra Therapeutics’s (137) Price Rate of Change (ROC) is -9.92, creating a Sell signal.

FAQ

Is 137 a Buy, Hold, or Sell?
Based on 137’s technical indicators, 137 is a Hold.
    What is 137’s RSI (14)?
    137’s RSI (14) is 44.76, which suggests 137 is a Neutral.
      What is 137’s MACD?
      137’s MACD is -0.05, which suggests 137 is a Buy.
        What is 137’s 5-day moving average?
        137’s 5-day moving average is 4.76, which suggests 137 is a Sell.
          What is 137’s 20-day moving average?
          137 20-day moving average is 5.01, which suggests 137 is a Sell.
            What is 137’s 50-day moving average?
            137’s 50-day moving average is 4.74, which suggests 137 is a Sell.
              What is 137’s 200-day moving average?
              137’s 200-day moving average is 3.68, which suggests 137 is a Buy.
                What is 137’s Williams % R (14)?
                137’s Williams % R (14) is -87.99, which suggests 137 is a Buy.
                  What is 137’s CCI (14)?
                  137’s CCI (14) is -75.58, which suggests 137 is a Neutral.
                    What is the share price of Aldeyra Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis